Novo and Lilly will sell their treatments to Medicare currently with list prices around $1,000 a month at reduced prices of around $250 a month, and in exchange, plans will eventually be required to cover the drugs for weight loss for high-risk patients
pooled 0.71 (0.610.83)]
Common adverse effects are gastrointestinal and usually dose-related
market protection years beyond the core molecules original patent expiration
While talking to The New Indian Express, Dr Naval Vikram, Physician, Diabetologist and Professor in the Department of Medicine at AIIMS-Delhi, and Dr Preethi Mrinalini K, General and Laparoscopic Surgeon at Apollo First Med Hospitals, Chennai, expressed deep concerns about the likely misuse of the drug
Most people report improvements in symptoms right after receiving B12 injections